Hudson Bay Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.22M | Buy |
475,000
+164,300
| +53% | +$2.84M | 0.03% | 290 |
|
|
2025
Q1 | $6.8M | Sell |
310,700
-34,300
| -10% | -$750K | 0.02% | 305 |
|
|
2024
Q4 | $11M | Buy |
345,000
+85,000
| +33% | +$2.71M | 0.04% | 230 |
|
|
2024
Q3 | $7.5M | Buy |
260,000
+145,000
| +126% | +$4.18M | 0.03% | 240 |
|
|
2024
Q2 | $4.41M | Buy |
115,000
+80,000
| +229% | +$3.07M | 0.02% | 323 |
|
|
2024
Q1 | $2.06M | Buy |
+35,000
| New | +$2.06M | 0.01% | 380 |
|
|
2023
Q4 | – | Sell |
-12,500
| Closed | -$476K | – | 635 |
|
|
2023
Q3 | $476K | Buy |
+12,500
| New | +$476K | ﹤0.01% | 518 |
|
|
2023
Q2 | – | Sell |
-50,000
| Closed | -$3.3M | – | 773 |
|
|
2023
Q1 | $3.3M | Buy |
+50,000
| New | +$3.3M | 0.03% | 371 |
|
|
2020
Q4 | – | Sell |
-60,000
| Closed | -$1.81M | – | 577 |
|
|
2020
Q3 | $1.81M | Buy |
+60,000
| New | +$1.81M | 0.03% | 357 |
|